All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Equity

GW hopes to go higher on Nasdaq

AIM-listed GW Pharmaceuticals, a £72m market capitalisation British firm that makes drugs from cannabinoids, is to list American depositary shares in the US, as the company’s London share price continues to slide.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree